nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC15A2—melanoma	0.833	1	CbGaD
Cefotaxime—SLC22A7—Docetaxel—melanoma	0.0451	1	CbGbCtD
Cefotaxime—Traumatic liver injury—Temozolomide—melanoma	0.00347	0.0336	CcSEcCtD
Cefotaxime—Induration—Bleomycin—melanoma	0.00343	0.0332	CcSEcCtD
Cefotaxime—Enterocolitis—Docetaxel—melanoma	0.0031	0.03	CcSEcCtD
Cefotaxime—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.00278	0.264	CbGpPWpGaD
Cefotaxime—Local reaction—Bleomycin—melanoma	0.00277	0.0268	CcSEcCtD
Cefotaxime—Nephropathy toxic—Bleomycin—melanoma	0.00267	0.0258	CcSEcCtD
Cefotaxime—Nephropathy toxic—Carmustine—melanoma	0.00233	0.0225	CcSEcCtD
Cefotaxime—Bullous eruption—Docetaxel—melanoma	0.00217	0.021	CcSEcCtD
Cefotaxime—Encephalopathy—Carmustine—melanoma	0.00208	0.0202	CcSEcCtD
Cefotaxime—Tenderness—Bleomycin—melanoma	0.00176	0.017	CcSEcCtD
Cefotaxime—Cholestasis—Temozolomide—melanoma	0.0017	0.0165	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00165	0.016	CcSEcCtD
Cefotaxime—Eosinophilia—Vemurafenib—melanoma	0.00157	0.0152	CcSEcCtD
Cefotaxime—Liver injury—Temozolomide—melanoma	0.00154	0.0149	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.0014	0.0136	CcSEcCtD
Cefotaxime—Aplastic anaemia—Dactinomycin—melanoma	0.00134	0.013	CcSEcCtD
Cefotaxime—Vaginal inflammation—Temozolomide—melanoma	0.00129	0.0125	CcSEcCtD
Cefotaxime—Candida infection—Carmustine—melanoma	0.00128	0.0124	CcSEcCtD
Cefotaxime—Candida infection—Temozolomide—melanoma	0.00123	0.0119	CcSEcCtD
Cefotaxime—Vaginal infection—Temozolomide—melanoma	0.00122	0.0118	CcSEcCtD
Cefotaxime—Aplastic anaemia—Temozolomide—melanoma	0.00121	0.0117	CcSEcCtD
Cefotaxime—Erythema multiforme—Vemurafenib—melanoma	0.0012	0.0116	CcSEcCtD
Cefotaxime—Ceftibuten—SLC15A2—melanoma	0.00104	0.13	CrCbGaD
Cefotaxime—Bronchospasm—Bleomycin—melanoma	0.000946	0.00915	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000934	0.00904	CcSEcCtD
Cefotaxime—Anaphylactic shock—Vemurafenib—melanoma	0.000902	0.00873	CcSEcCtD
Cefotaxime—Cefepime—SLC15A2—melanoma	0.000857	0.107	CrCbGaD
Cefotaxime—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000845	0.00818	CcSEcCtD
Cefotaxime—Neutropenia—Dactinomycin—melanoma	0.000838	0.00811	CcSEcCtD
Cefotaxime—Colitis—Docetaxel—melanoma	0.000825	0.00799	CcSEcCtD
Cefotaxime—Candida infection—Docetaxel—melanoma	0.000821	0.00794	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000793	0.00767	CcSEcCtD
Cefotaxime—Neutropenia—Carmustine—melanoma	0.000785	0.00759	CcSEcCtD
Cefotaxime—Cefuroxime—SLC15A2—melanoma	0.000776	0.0969	CrCbGaD
Cefotaxime—Haemoglobin—Bleomycin—melanoma	0.000773	0.00748	CcSEcCtD
Cefotaxime—Haemorrhage—Bleomycin—melanoma	0.00077	0.00745	CcSEcCtD
Cefotaxime—Neutropenia—Temozolomide—melanoma	0.000758	0.00734	CcSEcCtD
Cefotaxime—Agranulocytosis—Dactinomycin—melanoma	0.000746	0.00722	CcSEcCtD
Cefotaxime—Renal failure—Carmustine—melanoma	0.000736	0.00712	CcSEcCtD
Cefotaxime—Hepatitis—Dactinomycin—melanoma	0.000718	0.00694	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000717	0.00694	CcSEcCtD
Cefotaxime—Body temperature increased—Vemurafenib—melanoma	0.000713	0.0069	CcSEcCtD
Cefotaxime—Erythema multiforme—Dactinomycin—melanoma	0.000679	0.00657	CcSEcCtD
Cefotaxime—Haemoglobin—Carmustine—melanoma	0.000675	0.00653	CcSEcCtD
Cefotaxime—Haemorrhage—Carmustine—melanoma	0.000672	0.0065	CcSEcCtD
Cefotaxime—Cefixime—SLC15A2—melanoma	0.00067	0.0837	CrCbGaD
Cefotaxime—Hypersensitivity—Vemurafenib—melanoma	0.000665	0.00643	CcSEcCtD
Cefotaxime—Renal impairment—Docetaxel—melanoma	0.000656	0.00634	CcSEcCtD
Cefotaxime—Dermatitis bullous—Docetaxel—melanoma	0.000653	0.00632	CcSEcCtD
Cefotaxime—Haemoglobin—Temozolomide—melanoma	0.000652	0.00631	CcSEcCtD
Cefotaxime—Hepatitis—Temozolomide—melanoma	0.000649	0.00628	CcSEcCtD
Cefotaxime—Haemorrhage—Temozolomide—melanoma	0.000649	0.00628	CcSEcCtD
Cefotaxime—Pruritus—Vemurafenib—melanoma	0.000638	0.00618	CcSEcCtD
Cefotaxime—Ceftazidime—SLC15A2—melanoma	0.00063	0.0787	CrCbGaD
Cefotaxime—Ill-defined disorder—Bleomycin—melanoma	0.000622	0.00601	CcSEcCtD
Cefotaxime—Cefdinir—SLC15A2—melanoma	0.000619	0.0772	CrCbGaD
Cefotaxime—Diarrhoea—Vemurafenib—melanoma	0.000617	0.00597	CcSEcCtD
Cefotaxime—Erythema multiforme—Temozolomide—melanoma	0.000614	0.00594	CcSEcCtD
Cefotaxime—Cefaclor—SLC15A2—melanoma	0.000613	0.0766	CrCbGaD
Cefotaxime—Malaise—Bleomycin—melanoma	0.000604	0.00584	CcSEcCtD
Cefotaxime—Arrhythmia—Carmustine—melanoma	0.0006	0.00581	CcSEcCtD
Cefotaxime—Leukopenia—Bleomycin—melanoma	0.0006	0.0058	CcSEcCtD
Cefotaxime—Cefradine—SLC15A2—melanoma	0.000588	0.0734	CrCbGaD
Cefotaxime—Ill-defined disorder—Dactinomycin—melanoma	0.00058	0.00561	CcSEcCtD
Cefotaxime—Vomiting—Vemurafenib—melanoma	0.000574	0.00555	CcSEcCtD
Cefotaxime—Rash—Vemurafenib—melanoma	0.000569	0.0055	CcSEcCtD
Cefotaxime—Dermatitis—Vemurafenib—melanoma	0.000568	0.0055	CcSEcCtD
Cefotaxime—Headache—Vemurafenib—melanoma	0.000565	0.00547	CcSEcCtD
Cefotaxime—Discomfort—Bleomycin—melanoma	0.000563	0.00545	CcSEcCtD
Cefotaxime—Malaise—Dactinomycin—melanoma	0.000563	0.00545	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000562	0.00544	CcSEcCtD
Cefotaxime—Leukopenia—Dactinomycin—melanoma	0.000559	0.00541	CcSEcCtD
Cefotaxime—Cefadroxil—SLC15A2—melanoma	0.000556	0.0694	CrCbGaD
Cefotaxime—Anaphylactic shock—Bleomycin—melanoma	0.000547	0.00529	CcSEcCtD
Cefotaxime—Nausea—Vemurafenib—melanoma	0.000536	0.00519	CcSEcCtD
Cefotaxime—Thrombocytopenia—Bleomycin—melanoma	0.000535	0.00518	CcSEcCtD
Cefotaxime—Bronchospasm—Docetaxel—melanoma	0.00053	0.00513	CcSEcCtD
Cefotaxime—Discomfort—Dactinomycin—melanoma	0.000526	0.00508	CcSEcCtD
Cefotaxime—Ill-defined disorder—Temozolomide—melanoma	0.000524	0.00507	CcSEcCtD
Cefotaxime—Leukopenia—Carmustine—melanoma	0.000523	0.00506	CcSEcCtD
Cefotaxime—Angioedema—Temozolomide—melanoma	0.000516	0.005	CcSEcCtD
Cefotaxime—Malaise—Temozolomide—melanoma	0.00051	0.00493	CcSEcCtD
Cefotaxime—Convulsion—Carmustine—melanoma	0.000507	0.0049	CcSEcCtD
Cefotaxime—Leukopenia—Temozolomide—melanoma	0.000506	0.00489	CcSEcCtD
Cefotaxime—Neutropenia—Docetaxel—melanoma	0.000504	0.00488	CcSEcCtD
Cefotaxime—Thrombocytopenia—Dactinomycin—melanoma	0.000499	0.00483	CcSEcCtD
Cefotaxime—Convulsion—Temozolomide—melanoma	0.00049	0.00474	CcSEcCtD
Cefotaxime—Ceftriaxone—SLC15A2—melanoma	0.000478	0.0596	CrCbGaD
Cefotaxime—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000477	0.00461	CcSEcCtD
Cefotaxime—Discomfort—Temozolomide—melanoma	0.000475	0.0046	CcSEcCtD
Cefotaxime—Renal failure—Docetaxel—melanoma	0.000473	0.00457	CcSEcCtD
Cefotaxime—Jaundice—Docetaxel—melanoma	0.000469	0.00454	CcSEcCtD
Cefotaxime—Pain—Bleomycin—melanoma	0.000468	0.00452	CcSEcCtD
Cefotaxime—Thrombocytopenia—Carmustine—melanoma	0.000467	0.00452	CcSEcCtD
Cefotaxime—Anaphylactic shock—Temozolomide—melanoma	0.000461	0.00446	CcSEcCtD
Cefotaxime—Thrombocytopenia—Temozolomide—melanoma	0.000452	0.00437	CcSEcCtD
Cefotaxime—Feeling abnormal—Bleomycin—melanoma	0.000451	0.00436	CcSEcCtD
Cefotaxime—Agranulocytosis—Docetaxel—melanoma	0.000449	0.00434	CcSEcCtD
Cefotaxime—Pain—Dactinomycin—melanoma	0.000436	0.00422	CcSEcCtD
Cefotaxime—Urticaria—Bleomycin—melanoma	0.000434	0.0042	CcSEcCtD
Cefotaxime—Haemoglobin—Docetaxel—melanoma	0.000434	0.0042	CcSEcCtD
Cefotaxime—Body temperature increased—Bleomycin—melanoma	0.000432	0.00418	CcSEcCtD
Cefotaxime—Hepatitis—Docetaxel—melanoma	0.000432	0.00418	CcSEcCtD
Cefotaxime—Haemorrhage—Docetaxel—melanoma	0.000432	0.00418	CcSEcCtD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—XRCC3—melanoma	0.00043	0.0408	CbGpPWpGaD
Cefotaxime—Feeling abnormal—Dactinomycin—melanoma	0.00042	0.00407	CcSEcCtD
Cefotaxime—Cefalotin—SLC15A2—melanoma	0.000418	0.0522	CrCbGaD
Cefotaxime—Gastrointestinal pain—Dactinomycin—melanoma	0.000417	0.00403	CcSEcCtD
Cefotaxime—Erythema multiforme—Docetaxel—melanoma	0.000408	0.00395	CcSEcCtD
Cefotaxime—Pain—Carmustine—melanoma	0.000408	0.00395	CcSEcCtD
Cefotaxime—Abdominal pain—Dactinomycin—melanoma	0.000403	0.0039	CcSEcCtD
Cefotaxime—Body temperature increased—Dactinomycin—melanoma	0.000403	0.0039	CcSEcCtD
Cefotaxime—Hypersensitivity—Bleomycin—melanoma	0.000403	0.0039	CcSEcCtD
Cefotaxime—Pain—Temozolomide—melanoma	0.000394	0.00382	CcSEcCtD
Cefotaxime—Feeling abnormal—Carmustine—melanoma	0.000393	0.0038	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Carmustine—melanoma	0.00039	0.00378	CcSEcCtD
Cefotaxime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000388	0.0369	CbGpPWpGaD
Cefotaxime—Pruritus—Bleomycin—melanoma	0.000387	0.00374	CcSEcCtD
Cefotaxime—Arrhythmia—Docetaxel—melanoma	0.000386	0.00373	CcSEcCtD
Cefotaxime—Cephalexin—SLC15A2—melanoma	0.00038	0.0475	CrCbGaD
Cefotaxime—Feeling abnormal—Temozolomide—melanoma	0.00038	0.00368	CcSEcCtD
Cefotaxime—Body temperature increased—Carmustine—melanoma	0.000377	0.00365	CcSEcCtD
Cefotaxime—Abdominal pain—Carmustine—melanoma	0.000377	0.00365	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Temozolomide—melanoma	0.000377	0.00365	CcSEcCtD
Cefotaxime—Hypersensitivity—Dactinomycin—melanoma	0.000376	0.00363	CcSEcCtD
Cefotaxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.000374	0.0355	CbGpPWpGaD
Cefotaxime—Urticaria—Temozolomide—melanoma	0.000366	0.00354	CcSEcCtD
Cefotaxime—Abdominal pain—Temozolomide—melanoma	0.000365	0.00353	CcSEcCtD
Cefotaxime—Body temperature increased—Temozolomide—melanoma	0.000365	0.00353	CcSEcCtD
Cefotaxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.00036	0.0342	CbGpPWpGaD
Cefotaxime—Hypersensitivity—Carmustine—melanoma	0.000352	0.0034	CcSEcCtD
Cefotaxime—Diarrhoea—Dactinomycin—melanoma	0.000349	0.00338	CcSEcCtD
Cefotaxime—Vomiting—Bleomycin—melanoma	0.000348	0.00336	CcSEcCtD
Cefotaxime—Rash—Bleomycin—melanoma	0.000345	0.00334	CcSEcCtD
Cefotaxime—Dermatitis—Bleomycin—melanoma	0.000344	0.00333	CcSEcCtD
Cefotaxime—Hypersensitivity—Temozolomide—melanoma	0.00034	0.00329	CcSEcCtD
Cefotaxime—Leukopenia—Docetaxel—melanoma	0.000336	0.00325	CcSEcCtD
Cefotaxime—Diarrhoea—Carmustine—melanoma	0.000327	0.00316	CcSEcCtD
Cefotaxime—Pruritus—Temozolomide—melanoma	0.000326	0.00316	CcSEcCtD
Cefotaxime—Convulsion—Docetaxel—melanoma	0.000326	0.00315	CcSEcCtD
Cefotaxime—Nausea—Bleomycin—melanoma	0.000325	0.00314	CcSEcCtD
Cefotaxime—Vomiting—Dactinomycin—melanoma	0.000324	0.00314	CcSEcCtD
Cefotaxime—Rash—Dactinomycin—melanoma	0.000321	0.00311	CcSEcCtD
Cefotaxime—Diarrhoea—Temozolomide—melanoma	0.000316	0.00305	CcSEcCtD
Cefotaxime—Anaphylactic shock—Docetaxel—melanoma	0.000307	0.00297	CcSEcCtD
Cefotaxime—Vomiting—Carmustine—melanoma	0.000303	0.00294	CcSEcCtD
Cefotaxime—Nausea—Dactinomycin—melanoma	0.000303	0.00293	CcSEcCtD
Cefotaxime—Shock—Docetaxel—melanoma	0.000302	0.00292	CcSEcCtD
Cefotaxime—Rash—Carmustine—melanoma	0.000301	0.00291	CcSEcCtD
Cefotaxime—Dermatitis—Carmustine—melanoma	0.000301	0.00291	CcSEcCtD
Cefotaxime—Thrombocytopenia—Docetaxel—melanoma	0.0003	0.00291	CcSEcCtD
Cefotaxime—Headache—Carmustine—melanoma	0.000299	0.00289	CcSEcCtD
Cefotaxime—Vomiting—Temozolomide—melanoma	0.000293	0.00284	CcSEcCtD
Cefotaxime—Rash—Temozolomide—melanoma	0.000291	0.00281	CcSEcCtD
Cefotaxime—Dermatitis—Temozolomide—melanoma	0.000291	0.00281	CcSEcCtD
Cefotaxime—Headache—Temozolomide—melanoma	0.000289	0.0028	CcSEcCtD
Cefotaxime—Nausea—Carmustine—melanoma	0.000283	0.00274	CcSEcCtD
Cefotaxime—Nausea—Temozolomide—melanoma	0.000274	0.00265	CcSEcCtD
Cefotaxime—Pain—Docetaxel—melanoma	0.000262	0.00254	CcSEcCtD
Cefotaxime—Feeling abnormal—Docetaxel—melanoma	0.000253	0.00245	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Docetaxel—melanoma	0.000251	0.00243	CcSEcCtD
Cefotaxime—Abdominal pain—Docetaxel—melanoma	0.000242	0.00235	CcSEcCtD
Cefotaxime—Body temperature increased—Docetaxel—melanoma	0.000242	0.00235	CcSEcCtD
Cefotaxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000229	0.0217	CbGpPWpGaD
Cefotaxime—Hypersensitivity—Docetaxel—melanoma	0.000226	0.00219	CcSEcCtD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000221	0.021	CbGpPWpGaD
Cefotaxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.000221	0.0209	CbGpPWpGaD
Cefotaxime—Pruritus—Docetaxel—melanoma	0.000217	0.0021	CcSEcCtD
Cefotaxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000212	0.0201	CbGpPWpGaD
Cefotaxime—Diarrhoea—Docetaxel—melanoma	0.00021	0.00203	CcSEcCtD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—SMUG1—melanoma	0.000203	0.0193	CbGpPWpGaD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000201	0.019	CbGpPWpGaD
Cefotaxime—Vomiting—Docetaxel—melanoma	0.000195	0.00189	CcSEcCtD
Cefotaxime—Rash—Docetaxel—melanoma	0.000193	0.00187	CcSEcCtD
Cefotaxime—Dermatitis—Docetaxel—melanoma	0.000193	0.00187	CcSEcCtD
Cefotaxime—Headache—Docetaxel—melanoma	0.000192	0.00186	CcSEcCtD
Cefotaxime—Nausea—Docetaxel—melanoma	0.000182	0.00176	CcSEcCtD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000169	0.016	CbGpPWpGaD
Cefotaxime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000161	0.0153	CbGpPWpGaD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—ERCC2—melanoma	0.000151	0.0144	CbGpPWpGaD
Cefotaxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.00015	0.0142	CbGpPWpGaD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000141	0.0134	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000115	0.0109	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ABCB5—melanoma	0.000111	0.0105	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000111	0.0105	CbGpPWpGaD
Cefotaxime—Cefazolin—ALB—melanoma	0.000108	0.0135	CrCbGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000104	0.00989	CbGpPWpGaD
Cefotaxime—Ceftriaxone—ALB—melanoma	0.000103	0.0128	CrCbGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	0.000103	0.00975	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000102	0.0097	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ABCB5—melanoma	0.000101	0.00957	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.0001	0.00953	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.0001	0.00952	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	9.85e-05	0.00935	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	9.53e-05	0.00905	CbGpPWpGaD
Cefotaxime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	9.5e-05	0.00901	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	9.49e-05	0.009	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	9.28e-05	0.00881	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC6A11—melanoma	9.11e-05	0.00865	CbGpPWpGaD
Cefotaxime—Cefalotin—ALB—melanoma	9.01e-05	0.0112	CrCbGaD
Cefotaxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	8.81e-05	0.00836	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—melanoma	8.76e-05	0.00832	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	8.61e-05	0.00817	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ABCB5—melanoma	8.48e-05	0.00804	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC17A5—melanoma	8.44e-05	0.00801	CbGpPWpGaD
Cefotaxime—Cephalexin—ALB—melanoma	8.19e-05	0.0102	CrCbGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ARL2—melanoma	7.71e-05	0.00731	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC6A11—melanoma	7.66e-05	0.00727	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—melanoma	7.31e-05	0.00694	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	7.12e-05	0.00676	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ABCB5—melanoma	7.08e-05	0.00671	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC17A5—melanoma	7.04e-05	0.00668	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ARL2—melanoma	6.99e-05	0.00663	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	6.61e-05	0.00627	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC6A11—melanoma	6.39e-05	0.00607	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ARL2—melanoma	5.88e-05	0.00558	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC15A2—melanoma	5.84e-05	0.00554	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC17A5—melanoma	5.62e-05	0.00533	CbGpPWpGaD
Cefotaxime—SLC22A7—Fluoropyrimidine Activity—TP53—melanoma	5.4e-05	0.00512	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC15A2—melanoma	5.3e-05	0.00503	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	5.19e-05	0.00493	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC6A11—melanoma	5.1e-05	0.00484	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC17A5—melanoma	5.1e-05	0.00484	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	5.01e-05	0.00475	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ARL2—melanoma	4.9e-05	0.00465	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	4.82e-05	0.00457	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	4.72e-05	0.00447	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC6A11—melanoma	4.63e-05	0.00439	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—melanoma	4.59e-05	0.00436	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC15A2—melanoma	4.45e-05	0.00423	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	4.38e-05	0.00415	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC17A5—melanoma	4.29e-05	0.00407	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	4.24e-05	0.00403	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC5A5—melanoma	4.17e-05	0.00395	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	3.94e-05	0.00374	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC6A11—melanoma	3.89e-05	0.00369	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC15A2—melanoma	3.72e-05	0.00353	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC17A5—melanoma	3.58e-05	0.0034	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—melanoma	3.5e-05	0.00332	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC6A11—melanoma	3.25e-05	0.00308	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—melanoma	2.92e-05	0.00277	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC5A5—melanoma	2.33e-05	0.00221	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—ALB—melanoma	2.19e-05	0.00208	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	2.16e-05	0.00205	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC5A5—melanoma	2.12e-05	0.00201	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	2.02e-05	0.00192	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	2e-05	0.0019	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—ALB—melanoma	1.99e-05	0.00189	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	1.88e-05	0.00178	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC5A5—melanoma	1.78e-05	0.00169	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ABCB1—melanoma	1.78e-05	0.00169	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—ALB—melanoma	1.67e-05	0.00159	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	1.64e-05	0.00156	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ABCB1—melanoma	1.62e-05	0.00153	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	1.53e-05	0.00145	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC5A5—melanoma	1.49e-05	0.00141	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—ALB—melanoma	1.39e-05	0.00132	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ABCB1—melanoma	1.36e-05	0.00129	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ABCB1—melanoma	1.13e-05	0.00107	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ALB—melanoma	1.11e-05	0.00106	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	1.03e-05	0.000976	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ALB—melanoma	1.01e-05	0.000959	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	9.55e-06	0.000906	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ALB—melanoma	8.49e-06	0.000806	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	7.09e-06	0.000672	CbGpPWpGaD
